Home Cart Sign in  
Chemical Structure| 3133-16-2 Chemical Structure| 3133-16-2

Structure of 4-Octyl Itaconate
CAS No.: 3133-16-2

Chemical Structure| 3133-16-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4-Octyl itaconate is the endogenous metabolite of itaconate with anti-inflammatory activity. It can decrease cytokine production and protect against lipopolysaccharide-induced lethality in vivo.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 4-Octyl Itaconate

CAS No. :3133-16-2
Formula : C13H22O4
M.W : 242.31
SMILES Code : CCCCCCCCOC(CC(C(O)=O)=C)=O
MDL No. :MFCD31706409
InChI Key :KBASUIDPDITQHT-UHFFFAOYSA-N
Pubchem ID :14239884

Safety of 4-Octyl Itaconate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse bone marrow-derived macrophages (BMDMs) 125 μM 6 hours OI enhanced LPS-induced Nrf2 stabilization PMC6047741
wild type bone marrow-derived macrophages (BMDMs) 0.25 μM 3 hours or 12 hours To evaluate the intracellular accumulation and metabolic properties of 4OI in macrophages, it was found that 4OI is not converted to itaconate in macrophages and does not significantly increase succinate levels. PMC7378276
activated macrophages 0.25 μM 3 hours or 12 hours To evaluate the intracellular accumulation of 4OI in activated macrophages, it was found that 4OI does not significantly increase intracellular itaconate levels. PMC7378276
Human peripheral blood mononuclear cells (PBMCs) 50 µM 24 hours 4-OI suppressed osteoclast differentiation from RA and healthy donor-derived PBMCs, reduced the number of polynucleated TRAP-positive cells, and decreased the mRNA expression levels of osteoclast differentiation markers. PMC11671873
Murine bone marrow monocytes (BμMs) 100 µM 48 hours 4-OI inhibited the differentiation of WT and Acod1-deficient BμMs into mature osteoclasts, reduced the number of polynucleated TRAP-positive cells, and decreased the mRNA expression levels of osteoclast-related genes. PMC11671873
primary hepatocytes 10 μM 24 hours To evaluate the effect of 4-Octyl Itaconate on lipid accumulation in hepatocytes, results showed it significantly reduced lipid accumulation and enhanced oxidative phosphorylation. PMC10290955
HepG2 cells 10 μM 24 hours To evaluate the effect of 4-Octyl Itaconate on lipid accumulation in human hepatocytes, results showed it significantly reduced lipid accumulation. PMC10290955
RAW264.7 macrophages 62.5 μM 24 hours To detect GAPDH enzyme activity, results showed that GAPDH activity was inhibited in LPS-induced macrophages after 4-OI treatment for 24 h. PMC6841710
bone marrow-derived macrophages (BMDMs) 62.5 μM 24 hours To detect lactate levels, results showed that lactate levels were significantly reduced in LPS-induced BMDMs after 4-OI treatment. PMC6841710
Mouse bone marrow-derived macrophages (BMDMs) 125-250 µM 1 hour Inhibited LPS-induced Casp11 expression, reducing macrophage pyroptosis and subsequent tissue factor (TF) release. PMC10265568
Human peripheral blood mononuclear cells (PBMCs) 125-250 µM 1 hour Inhibited LPS-induced F3 mRNA expression, reducing tissue factor (TF) release. PMC10265568
Human umbilical vein endothelial cells (HUVECs) 75 μM 12 hours To evaluate the protective effect of 4-OI on H2O2-induced cell damage, results showed that 4-OI significantly increased cell viability, reduced apoptosis, and enhanced angiogenic capacity. PMC11904966

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice LPS-induced sepsis model intraperitoneally 50 mg/kg Daily for 15 days OI prolonged survival, decreased clinical score, improved body temperature regulation, and decreased IL-1β and TNF levels PMC6047741
Mice K/BxN serum-induced arthritis model Intraperitoneal injection 100 µg PGZ-Exos in 100 µl PBS On post-operative days 0, 3, 7, 10, and 14 4-OI treatment alleviated inflammation and bone erosion in the K/BxN serum-induced arthritis model, reduced the number of osteoclasts in the joints, and reversed the metabolic shift towards glycolysis in OCPs. PMC11671873
mice high-fat diet-induced NAFLD model intraperitoneal injection 1 mg Days 1, 3, 5, and 7, lasting for 7 days To evaluate the therapeutic effect of 4-Octyl Itaconate on high-fat diet-induced NAFLD in mice, results showed it significantly reversed hyperlipidemia and fatty liver symptoms. PMC10290955
C57BL/6J mice lethal endotoxaemia model intraperitoneal injection 50 mg/kg three times per week for 12 weeks 4-OI significantly improved the survival rate of mice and reduced the serum levels of IL-1β, IL-6, and lactate. PMC6841710
Mice LPS-induced inflammation and coagulopathy model Intraperitoneal injection 15 to 45 mg/day Daily, average 34.5 months Inhibited LPS-induced thrombin generation, improving survival in mice. PMC10265568
Mice Myocardial ischemia-reperfusion injury model Intraperitoneal injection 0.6 g/liter Starting at 2 weeks of gestation, continuing throughout lactation, and maintained after weaning To evaluate the protective effect of 4-OI on myocardial ischemia-reperfusion injury, results showed that 4-OI significantly reduced myocardial damage, enhanced angiogenesis, and improved cardiac function. PMC11904966

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.13mL

0.83mL

0.41mL

20.63mL

4.13mL

2.06mL

41.27mL

8.25mL

4.13mL

 

Historical Records

Categories